Table 2. Demographic features of all AKI patients and control subjects.
AKI | |||||
---|---|---|---|---|---|
Regenerating | |||||
Characteristic | Total | Control | Mild | Dialysis | Fibrogenesis |
Number | 43 | 10 | 15 | 8 | 10 |
Gender | |||||
Male | 24 | 6 | 12 | 5 | 1 |
Female | 19 | 4 | 3 | 3 | 9 |
Age | 48 (15–73) | 45 (23–60) | 43 (15–66) | 42.5 (29–73) | 57 (38–69) |
Aetiology | |||||
Renal ischaemia | 11 | 0 | 3 | 5 | 3 |
Nephrotoxic drug | 3 | 0 | 1 | 0 | 2 |
Ischaemia or drug | 14 | 0 | 7 | 2 | 5 |
Rhabdomyolysis | 5 | 0 | 4 | 1 | 0 |
Minimal change | 7 | 7 | 0 | 0 | 0 |
Mild mesangial proliferation | 3 | 3 | 0 | 0 | 0 |
Time of biopsy after onset | – | – | 8.5 (2.7) | 11.1 (5.6) | 42.3 (14.1) |
eGFR (Cockcroft–Gault) | 25.2 (3.71–106.6) | 88.45 (73.5–106.6) | 22.89 (7.33–68.31) | 8.32 (3.71–10.41) | 20.34 (7.34–34.12) |